The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions

NCT04476719 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: ATAFENOVIR 200 MG KAPSUL
DRUG: ARBIDOL 100 MG KAPSUL

Sponsor

Atabay Kimya Sanayi Ticaret A.S.

Collaborators

[object Object]
[object Object]